# Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon

> **NCT04829695** · PHASE4 · UNKNOWN · sponsor: **University of Yaounde 1** · enrollment: 184 (estimated)

## Conditions studied

- Falciparum Malaria

## Interventions

- **DRUG:** Artesunate-amodiaquine drug combination
- **DRUG:** Artemether-lumefantrine drug combination

## Key facts

- **NCT ID:** NCT04829695
- **Lead sponsor:** University of Yaounde 1
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-05
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2021-04-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04829695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04829695, "Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04829695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*